Rising incidence of contagious diseases is a major factor influencing market growth.
Market Size – USD 9.72 billion in 2018, Market Growth - CAGR of 13.1 %, Market Trends –Rise in targeted immunotherapy adoption, along with an increase in R&D investment of biotechnology and pharmaceutical companies
The Antibody Production market is expected to reach USD 26.16 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the increasing prevalence of contagious diseases globally, coupled with the expanding demand for protein therapeutics, which is promoting the development of the global market. The clinical and commercial progress of monoclonal antibodies has resulted in the need for production of antibodies in mammalian cell culture on a large-scale. Based on statistics, the rise in targeted immunotherapy adoption along with enhanced acceptance by regulatory authorities for therapeutic antibodies and an increase in R&D investment of biotechnology and pharmaceutical companies stimulate the growth of the global market. Also, the rise in the prevalence of infectious diseases and growth in demand for protein therapeutics is expected to spur the market growth further. However , expensive primary antibodies will restrain the growth.
Antibodies also acknowledged as immunoglobulins, are abundant Y-shaped proteins that are generated by plasma cells, and are utilized by the immune system to neutralize pathogens such as viruses and bacteria. The immune system responds to external materials or antigens penetrating inside the body by producing antibodies. The two main types of antibodies are polyclonal and monoclonal antibodies, which can also be produced by techniques like hybridoma. The natural ability to create antibodies that can connect antigens can be used in the manufacturing of probes to identify distinct molecules of interest across a wide spectrum of diagnostic applications and research.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1404
The report provides a complete analysis of the global Antibody Production market with important details about the key market players from insightful primary and secondary research data. The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.
The key companies profiled in the market are:
Thermo Fisher Scientific, Inc., GeneTex, Inc., Eli Lilly and Company, Pall Corporation, Merck KGaA, , Eppendorf AG, Cellab GmbH, Abcam PLC, Sigma-Aldrich Corporation FiberCell Systems Inc.
Further key findings from the report suggest
- The therapeutics are incredibly useful for treating cancer, rheumatoid arthritis, and other chronic diseases
- The growing incidence of contagious diseases, coupled with expanding demand for protein therapeutics is expected to drive the growth of the market.
- Other factors that are responsible for the growth of the market are raised R&D disbursement on biotechnology and pharmaceutical companies, the patent cessation of prosperous monoclonal antibodies, therapeutic antibodies by governing authorities, and acceptance of targeted immunotherapy.
- The monoclonal class segment is estimated to reach USD 10.33 billion by 2026 at a CAGR of 13.2% during the forecast period.
- Due to the growing demand in the treatment of chronic diseases including blood disorders, cancer, and growth hormone deficiency, this segment is expected to hold a significant share during the forecast period.
- This downstream procedure includes the application of accurate, highly sophisticated, and effective products that include chromatography instruments & resins.
- The potency of cell cultures has increased over the past decade, leading to process optimization and improved yield.
- Apart from leveling up the process and cost-effectiveness, decrease in time required during the development of processes is being practiced by several players.
- The downstream process segment is estimated to reach USD 9.37 billion by 2026.
- The upstream process is expected to reach USD 8.35 billion by 2026 at a CAGR of 13.1% during the forecast period.
- The pharmaceutical and biotechnology companies of the end user segment is estimated to reach USD 10.15 billion by 2026.
- Due to the massive production of therapeutic antibodies and high R&D investment by companies for drug improvement, this segment is expected to grow significantly during the forecast period.
- Research Institutes of the end user segment is estimated to reach USD 7.90 billion by 2026 at the highest CAGR of 13.2% during the forecast period.
- The market in APAC is anticipated to be the fastest growing region with the highest CAGR of 13.2% during the forecast period, due to the rapidly evolving biotechnology industries in this region.
For the purpose of this study, Reports and Data have segmented the global Antibody production market on the basis of Class, End-User, Process and Region:
Class Outlook (Revenue, USD Million; 2016-2026)
- Monoclonal antibodies
- Murine
- Chimeric
- Humanized
- Polyclonal Antibodies
End User Outlook (Revenue, USD Million; 2016-2026)
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Research Institutes
Process Outlook (Revenue, USD Million; 2016-2026)
- Upstream Processing
- Downstream Processing
Browse Complete Report “Antibody Production Market” @ https://www.reportsanddata.com/report-detail/antibody-production-market
The report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region. The Antibody Production market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
In-depth regional analysis covers:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- Rest of MEA
The report includes primary and subjective research with a comprehensive study examined and validated by industry professionals and experts. The report further provides insights into the opportunities and threats that the industry may witness in the upcoming years, throughout the forecast period. The report also provides an insight into the growth in revenue along with CAGR throughout the forecast period. It also provides insights into lucrative opportunities to enable the businesses to capitalize on the emerging trends of the market.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1404
Highlights of the TOC:
- Report Overview
1.1 Research Scope
1.2 Key Antibody Production market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline
- Global Growth Trends
2.1 Global Antibody Production market size
2.2 Latest Antibody Production market trends
2.3 Key growth trends
- Competitive Landscape
3.1 Global Antibody Production market key players
3.2 Global Antibody Production size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the Antibody Production market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Thank you for reading our report. For additional information on customization of the report, connect with us and we will make sure you get a report tailored to meet your needs.
Antibody Production Market, Antibody Production Market size, Antibody Production Market share, Antibody Production Market trends, Antibody Production Market forecast, Antibody Production Market analysis, Antibody Production Market scope, Antibody Production Market manufacturer, Antibody Production Market vendors, Antibody Production Market players, Antibody Production Market top player, Antibody Production Market key player, Antibody Production Market prominent player, Antibody Production Market major manufacturers, Antibody Production Market report .
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
The Global Antibody Production Market report encompasses vital information about the Antibody Production market that offers valuable insights about the dynamics of the Antibody Production market to the readers and businesses.
The report presents key statistical data about the Antibody Production market for the forecast timeline of 2020-2026, covering historical analysis, demands and supply dynamics, current and emerging trends, and revenue estimations.
The report consists of total market insight based on the company, major countries, and applications and types in the competitive market.
The report strives to provide an accurate estimation of the market trends for the Antibody Production market from the year 2020 to the year 2027.
The research report consists of a complete market analysis, including financial standing, revenue estimation, limitations, and dynamics that might affect the market.The report is generated according to the latest economic landscape in tune with the COVID-19 crisis.
The pandemic has affected the global economic scenario, and the report provides details about its impact on the overall industry.
Global Antibody Production Market is expected to grow at a CAGR of 14.2% to reach US$ 16.32 billion in 2024.
The increasing focus of biopharmaceutical & biotechnology companies to produce antibody therapeutics is a major factor driving the growth.
The Global Antibody Production Market is driven by the factor including the presence of many large biotechnology and biopharmaceutical firms in this region.
In addition, the highly developed healthcare & research infrastructure and increased focus on drug discovery in North America have fuelled the regional Global Antibody Production Market growth.
There are many biopharmaceutical and clinical research organizations companies, which are targeting Asian countries, such as China & India for drug discovery and development.
The presence of less stringent regulations for antibodies development & production, vast genome pool, and developing healthcare infrastructure in this region are some of the major factors contributing to the growth of the sector in this region.
The Global Antibody Production Market research report offers accurate insights for the growth prospects of the Antibody Production market in the forecast years 2020-2027.
The report is an all-inclusive study of the Antibody Production market that offers the readers a better view of the current and emerging market trends through a thorough analysis of the market size, growth trends, supply and demand ratio, market share, sales network and distribution channels, and other key elements.Furthermore, the report is furnished with the current market scenario with regards to the COVID-19 pandemic.
The global public health emergency has disrupted the lives of everyone across the globe.
It has also had a substantial impact on the Antibody Production industry as global supply chains have been disrupted, and the financial scenario is tight.
The report assesses the initial and future impact of the pandemic on the market and its key segments to offer an accurate futuristic outlook for remuneration in a post-COVID-19 scenario.Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1404Scope of the Market Report:The report offers a holistic overview of the Antibody Production industry that offers all the essential information.
The report is formulated by extensive primary and secondary research and backed by the verified data from industry experts and professionals.
